Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
8 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
The COMPARE head-to-head, randomized controlled trial of SEL-212 (pegadricase plus rapamycin-containing nanoparticle, ImmTOR™) versus pegloticase for refractory gout.
Rheumatology (Oxford). 2024 Apr 2;63(4):1058-1067. doi: 10.1093/rheumatology/kead333.
Rheumatology (Oxford). 2024.
PMID: 37449908
Free PMC article.
Clinical Trial.
Phase 2 Dose-Finding Study in Patients with Gout Using SEL-212, a Novel PEGylated Uricase (SEL-037) Combined with Tolerogenic Nanoparticles (SEL-110).
Kivitz A, DeHaan W, Azeem R, Park J, Rhodes S, Inshaw J, Leung SS, Nicolaou S, Johnston L, Kishimoto TK, Traber PG, Sands E, Choi H.
Kivitz A, et al. Among authors: dehaan w.
Rheumatol Ther. 2023 Aug;10(4):825-847. doi: 10.1007/s40744-023-00546-0. Epub 2023 Apr 17.
Rheumatol Ther. 2023.
PMID: 37069364
Free PMC article.
Item in Clipboard
Tolerogenic nanoparticles mitigate the formation of anti-drug antibodies against pegylated uricase in patients with hyperuricemia.
Sands E, Kivitz A, DeHaan W, Leung SS, Johnston L, Kishimoto TK.
Sands E, et al. Among authors: dehaan w.
Nat Commun. 2022 Jan 12;13(1):272. doi: 10.1038/s41467-021-27945-7.
Nat Commun. 2022.
PMID: 35022448
Free PMC article.
Item in Clipboard
A New Natural Defense Against Airborne Pathogens.
Edwards D, Hickey A, Batycky R, Griel L, Lipp M, Dehaan W, Clarke R, Hava D, Perry J, Laurenzi B, Curran AK, Beddingfield BJ, Roy CJ, Devlin T, Langer R.
Edwards D, et al. Among authors: dehaan w.
QRB Discov. 2020 Jul 7;1:e5. doi: 10.1017/qrd.2020.9. eCollection 2020.
QRB Discov. 2020.
PMID: 34192261
Free PMC article.
Item in Clipboard
Pulmonary and Regional Deposition of Nebulized and Dry Powder Aerosols in Ferrets.
Kuehl PJ, Chand R, McDonald JD, Hava DL, DeHaan WH.
Kuehl PJ, et al. Among authors: dehaan wh.
AAPS PharmSciTech. 2019 Jul 1;20(6):242. doi: 10.1208/s12249-019-1382-3.
AAPS PharmSciTech. 2019.
PMID: 31264190
Item in Clipboard
Characteristics of exhaled particle production in healthy volunteers: possible implications for infectious disease transmission.
Wurie F, Le Polain de Waroux O, Brande M, Dehaan W, Holdgate K, Mannan R, Milton D, Swerdlow D, Hayward A.
Wurie F, et al. Among authors: dehaan w.
F1000Res. 2013 Jan 15;2:14. doi: 10.12688/f1000research.2-14.v1. eCollection 2013.
F1000Res. 2013.
PMID: 24555026
Free PMC article.
Item in Clipboard
Influenza virus in human exhaled breath: an observational study.
Fabian P, McDevitt JJ, DeHaan WH, Fung RO, Cowling BJ, Chan KH, Leung GM, Milton DK.
Fabian P, et al. Among authors: dehaan wh.
PLoS One. 2008 Jul 16;3(7):e2691. doi: 10.1371/journal.pone.0002691.
PLoS One. 2008.
PMID: 18628983
Free PMC article.
Item in Clipboard
In vitro monodisperse aerosol deposition in a mouth and throat with six different inhalation devices.
DeHaan WH, Finlay WH.
DeHaan WH, et al.
J Aerosol Med. 2001 Fall;14(3):361-7. doi: 10.1089/089426801316970321.
J Aerosol Med. 2001.
PMID: 11693848
Item in Clipboard
Cite
Cite